| Literature DB >> 36231251 |
Shuoqi Li1, Rong Guo2, Tao Yu3, Shiming Li4, Tenghai Han5, Wenbing Yu4.
Abstract
BACKGROUND: High-intensity interval training (HIIT) and blood flow restriction (BFR) represent a critical nonpharmacological strategy to reduce the excess deposition of visceral fat, as well as relevant complications, among obese populations. Applying BFR at diverse phases may have different effects. Therefore, the exercise program of this study combined HIIT with BFR, so as to explore the effect of BFR on abdominal visceral fat area and its mechanism in different periods of HIIT. The aim is to provide a more effective exercise prescription for obese people who want to reduce visceral fat quickly.Entities:
Keywords: blood flow restriction; high-intensity interval training; visceral fat
Mesh:
Substances:
Year: 2022 PMID: 36231251 PMCID: PMC9565218 DOI: 10.3390/ijerph191911936
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Figure 1Flowchart of study design.
Figure 2Experimental design and exercise program. Note: = phase of blood flow restriction; = fasting blood collection in the morning; = dual-energy X-ray test; = maximum oxygen uptake test; = computed tomography test; = blood collection before and after acute exercise.
Physical characteristics of the participants and the changes in VO2max.
| C Group ( | H Group ( | E Group ( | I Group ( | |
|---|---|---|---|---|
| Age (years) | 21.5 ± 1.5 | 21.8 ± 1.8 | 22.1 ± 2.0 | 21.6 ± 1.9 |
| Height (cm) | 166.7 ± 9.0 | 168.0 ± 8.5 | 166.2 ± 8.9 | 166.6 ± 9.2 |
| Weight (kg) | 74.6 ± 7.5 | 74.4 ± 7.4 | 73.5 ± 9.3 | 75.4 ± 9.7 |
| BMI (kg/m2) | 26.8 ± 2.0 | 26.3 ± 1.1 | 26.5 ± 1.4 | 27.1 ± 1.5 |
| VO2max (mL/kg/min) | ||||
| 0 weeks | 31.3 ± 5.1 | 32.9 ± 5.1 | 32.0 ± 4.8 | 32.6 ± 6.1 |
| 4 weeks | 34.7 ± 4.7 a | 34.2 ± 5.1 a | 34.9 ± 4.1 a | |
| 8 weeks | 36.1 ± 4.4 a,b | 36.0 ± 5.4 a,b | 37.1 ± 6.1 a,b | |
| 12 weeks | 31.7 ± 5.2 | 36.9 ± 5.9 a,b,d | 37.8 ± 5.3 a,b,c,d | 38.6 ± 6.2 a,b,c,d |
Note: a statistical difference with 0 weeks; b statistical difference with 4 weeks; c statistical difference with 8 weeks; d statistical difference with C group value.
Calorie expenditure and intake.
| C Group | H Group | E Group | I Group | |||||
|---|---|---|---|---|---|---|---|---|
| Pre | 12 Weeks | Pre | 12 Weeks | Pre | 12 Weeks | Pre | 12 Weeks | |
| Estimated daily energy intake (kJ/day) | 8236.9 ± 555.3 | 8288.9 ± 556.2 | 8113.9 ± 571.5 | 8066.4 ± 595.4 | 8159.0 ± 725.8 | 8220.0 ± 698.3 | 8123.6 ± 587.7 | 8162.1 ± 627.4 |
| Estimated daily energy expenditure (kJ/day) | 1952.9 ± 252.1 | 2002.8 ± 277.8 | 2016.4 ± 286.1 | 1929.6 ± 233.4 | 2024.1 ± 311.8 | 2033.5 ± 309.9 | 2004.2 ± 285.8 | 2041.4 ± 278.5 |
Exercise intensity, HR, RPE, and LOP of each group.
| H Group | E Group | I Group | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1–4 Weeks | 4–8 Weeks | 8–12 Weeks | 1–4 Weeks | 4–8 Weeks | 8–12 Weeks | 1–4 Weeks | 4–8 Weeks | 8–12 Weeks | |
| Exercise intensity (W) | 143.2 ± 31.5 | 159.4 ± 27.7 a | 175.4 ± 25.2 a,b | 146.8 ± 30.8 | 161.9 ± 27.1 a | 173.0 ± 26.9 a,b | 144.6 ± 32.5 | 167.4 ± 29.8 a | 177.1 ± 28.7 a,b |
| HR (beats/min) | 168.9 ± 12.5 | 171.1 ± 6.9 | 171.7 ± 12.1 | 173.8 ± 10.8 | 176.5 ± 9.1 | 174.1 ± 7.7 | 178.4 ± 11.0 c | 181.6 ± 9.2 c | 181.4 ± 13.4 c |
| RPE | 16.6 ± 0.9 | 16.5 ± 0.6 | 16.4 ± 0.9 | 16.5 ± 0.7 | 16.9 ± 0.7 | 16.6 ± 0.9 | 16.6 ± 1.1 | 16.9 ± 0.8 | 16.9 ± 0.9 |
| LOP | 204.8 ± 10.8 | 202.4 ± 10.3 | 203.8 ± 8.8 | 203.4 ± 13.3 | 208.8 ± 10.3 | 207.7 ± 13.6 | |||
| 40% LOP | 81.9 ± 4.3 | 80.9 ± 4.1 | 81.5 ± 3.5 | 81.4 ± 5.3 | 83.5 ± 4.1 | 83.1 ± 5.4 | |||
Note: a significant difference compared with 1–6 weeks; b significant difference compared with 1–6 weeks; c significant difference compared with the H group; HR = heart rate; RPE = rating of perceived exertion; LOP = limb occlusive pressure.
Changes of fat variables in each group.
| C Group | H Group | E Group | I Group | Two-Way ANOVA (Group, Time, Interaction) | |||||
|---|---|---|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | Pre | Post | ||
| % Body fat (%) | 40.8 ± 3.5 | 41.0 ± 3.5 | 40.6 ± 3.6 | 38.4 ± 3.5 a | 40.2 ± 2.5 | 37.2 ± 2.4 a | 40.6 ± 2.6 | 37.5 ± 2.6 a | (0.209, 0.001, 0.001) |
| 0.2 ± 0.6 | −2.1 ± 0.9 b | −3.0 ± 1.1 bc | −3.1 ± 0.9 b,c | ||||||
| Whole-body FM (kg) | 31.2 ± 5.7 | 31.3 ± 5.6 | 31.3 ± 4.4 | 28.8 ± 4.6 a | 30.9 ± 5.0 | 27.8 ± 4.8 a | 30.7 ± 3.8 | 27.3 ± 4.4 a | (0.566, 0.001, 0.001) |
| 0.1 ± 0.6 | −2.5 ± 1.1 b | −3.1 ± 1.2 b | −3.4 ± 1.2 b,c | ||||||
| Android FM (kg) | 2.5 ± 0.5 | 2.5 ± 0.5 | 2.6 ± 0.6 | 2.4 ± 0.5 a | 2.5 ± 0.6 | 2.3 ± 0.5 a | 2.7 ± 0.6 | 2.4 ± 0.6 a | (0.904, 0.001, 0.001) |
| 0.0 ± 0.1 | −0.2 ± 0.1 b | −0.2 ± 0.1 b | −0.3 ± 0.1 b,c | ||||||
| Gynoid FM (kg) | 5.7 ± 0.4 | 5.7 ± 0.5 | 5.9 ± 0.6 | 5.5 ± 0.5 a | 5.8 ± 0.6 | 5.4 ± 0.6 a | 6.0 ± 0.6 | 5.6 ± 0.6 a | (0.875, 0.001, 0.001) |
| 0.0 ± 0.1 | −0.4 ± 0.2 b | −0.4 ± 0.1 b | −0.4 ± 0.2 b | ||||||
| Trunk FM (kg) | 16.6 ± 2.3 | 16.6 ± 2.2 | 16.9 ± 2.2 | 15.6 ± 2.0 a | 17.0 ± 1.8 | 15.1 ± 1.7 a | 17.5 ± 2.0 | 15.6 ± 2.1 a | (0.867, 0.001, 0.001) |
| 0.0 ± 0.2 | −1.3 ± 0.6 b | −1.9 ± 0.4 b,c | −1.9 ± 0.7 b,c | ||||||
Note: a significant difference compared with Pre; b significant difference compared with C group; c significant difference compared with the H group; FM = fat mass.
Figure 3Changes in AVFA (a) and ASFA (b) before and after intervention. Note: a statistical difference relative to Pre; b statistical difference relative to C group; c statistical difference relative to H group; d statistical difference relative to E group.
Figure 4Changes in blood glucose (a), insulin (b), triglyceride (c), and total cholesterol (d) before and after intervention. Note: a statistical difference relative to Pre; b statistical difference relative to C group; c statistical difference relative to H group.
Figure 5Changes in GH (a), EPI (b), and LA (c) after exercise. Note: a statistical difference in E group compared with H group; b statistical difference in I group compared with H group; c statistical difference in I group compared with E group. GH = growth hormone; EPI = epinephrine; LA = lactic acid.